Endothelin receptor B, a candidate gene from human studies at high altitude, improves cardiac tolerance to hypoxia in genetically engineered heterozygote mice

Tsering Stobdan,Dan Zhou,Eilleen Ao-Ieong,Daniel Ortiz,Roy Ronen,Iain Hartley,Zhuohui Gan,Andrew D. McCulloch,Vineet Bafna,Pedro Cabrales,Gabriel G. Haddad
DOI: https://doi.org/10.1073/pnas.1507486112
IF: 11.1
2015-08-03
Proceedings of the National Academy of Sciences
Abstract:Significance Although model organisms have been used to understand the underlying basis of hypoxia and how to treat it, it has always been useful to learn from natural experiments in humans, such as in high-altitude dwellers. In this study, we demonstrate that decreased Endothelin receptor type B ( EdnrB ), a gene associated with altitude adaptation from our human study, improves cardiac tolerance to hypoxia. We show that heterozygote EdnrB mice maintain higher cardiac output and peripheral perfusion and better O 2 delivery to vital organs, even in severe hypoxia. Furthermore, the transcriptome profile revealed three atria-specific genes, natriuretic peptide type A ( Nppa ), sarcolipin ( Sln ), and myosin light polypeptide 4 ( Myl4 ), which were down-regulated by hypoxia and possibly have a role in improving cardiac performance during normoxia and hypoxia.
multidisciplinary sciences
What problem does this paper attempt to address?